GlassScriptPhysician profile
Timothy Hunter Schmidt
NPI 1720475197
$856.07
in general payments reported to CMS, 2019-2025
14 companies · $19.85 in 2025
The $19.85 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $185 · 2021: $617 · 2022: $21.38 · 2023: $12.76 · 2025: $19.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $222.07 | 2020-2023 | Botox |
| Genentech USA, INC. | $140.50 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $111.23 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $90.77 | 2020-2022 | |
| Genzyme Corporation | $88.70 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $50.99 | 2021 | |
| Janssen Biotech, INC. | $25.40 | 2021 | |
| Abbott Laboratories | $19.85 | 2025 | Freestyle Libre 3 |
| Allergan, INC. | $18.96 | 2020 | |
| Leo Pharma INC. | $18.44 | 2021 | |
| Lilly USA, LLC | $18.36 | 2021 | |
| Pfizer INC. | $18.05 | 2021 | |
| Galderma Laboratories, L.P. | $17.26 | 2021 | |
| Almirall LLC | $15.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.